TUOXIN

About:

TUOXIN is a pharmaceutical company that specializes in R&D and production of nucleosides acid.

Website: http://www.tuoxinchem.com/

Top Investors: CICC Wealth Management, Macrolink Group, Southwest Securities

Description:

TUOXIN is a high-tech enterprise integrating the R&D, production, and sales of chemical synthesis and biological fermentation of nucleoside pharmaceutical intermediates. They offer nucleoside fermentation technology platforms and biotransformation semi-synthesis technology platforms and products, such as cytosine, 5-fluorocytosine, cytidine, and other pharmaceutical intermediates.

Total Funding Amount:

53M CNY

Headquarters Location:

Xinxiang, Henan, China

Founded Date:

2005-02-03

Contact Email:

tuoxin(AT)tuoxinpharm.com

Founders:

Number of Employees:

101-250

Last Funding Date:

2015-09-28

IPO Status:

Public

Industries:

© 2025 bioDAO.ai